GRCE

Grace Therapeutics, Inc. Common Stock
GRCE

Overview Fund Activity

28 hedge funds and large institutions have $1.44M invested in Grace Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$625K
2
VF
2
Virtu Financial
New York
$224K
3
Citadel Advisors
3
Citadel Advisors
Florida
$89K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$56K
5
HF
5
HRT Financial
New York
$14K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
Thrivent Financial for Lutherans
2
Thrivent Financial for Lutherans
Minnesota
$0
3
TSS
3
Two Sigma Securities
New York
$0
4
SIG
4
Sargent Investment Group
Maryland
$0
5
AAS
5
Avantax Advisory Services
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– -$12K -1,274 Closed
SIG
27
Sargent Investment Group
Maryland
– -$3K -349 Closed
AAS
28
Avantax Advisory Services
Texas
– -$3K -349 Closed
TSS
29
Two Sigma Securities
New York
– -$3K -326 Closed
Thrivent Financial for Lutherans
30
Thrivent Financial for Lutherans
Minnesota
– -$6K – –
1
2